Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial ResultsGlobeNewsWire • 03/02/22
Verrica Pharmaceuticals Announces Participation in the 42nd Annual Cowen Virtual Healthcare ConferenceGlobeNewsWire • 02/24/22
Verrica Pharmaceuticals Announces Acceptance by FDA of NDA Resubmission for VP-102 for the Treatment of Molluscum ContagiosumGlobeNewsWire • 12/15/21
Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum ContagiosumGlobeNewsWire • 11/29/21
Verrica Pharmaceuticals Announces FDA Acceptance of its IND Application for LTX-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell CarcinomaGlobeNewsWire • 11/18/21
Does Verrica Pharmaceuticals Inc. (VRCA) Have the Potential to Rally 60% as Wall Street Analysts Expect?Zacks Investment Research • 10/11/21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Verrica Pharmaceuticals Inc. -VRCAPRNewsWire • 09/23/21
Verrica Pharmaceuticals Receives Complete Response Letter from the FDA identifying deficiencies at a facility of a Contract Manufacturer for its New Drug Application for VP-102 for the Treatment of Molluscum ContagiosumGlobeNewsWire • 09/20/21
Verrica Pharmaceuticals Announces Appointment of Terry Kohler as Chief Financial OfficerGlobeNewsWire • 07/09/21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. - VRCANewsfile Corp • 06/06/21
Verrica's VP-102 Application Review for Molluscum Contagiosum Delayed till SeptemberBenzinga • 05/28/21
Verrica Pharmaceuticals Announces Extension of FDA Review Period of its NDA for VP-102 for the Treatment of Molluscum ContagiosumGlobeNewsWire • 05/28/21
Verrica Pharmaceuticals Announces Participation in the Jefferies Virtual Healthcare ConferenceGlobeNewsWire • 05/26/21
Verrica Pharmaceuticals Announces Participation in the 2021 RBC Capital Markets Global Healthcare ConferenceGlobeNewsWire • 05/12/21
Verrica Pharmaceuticals Announces Participation in the 20th Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/06/21